Bisphosphonates in oncology: Breast cancer and beyond

被引：3

作者：

Tripathy, D

机构：

[1] Univ Calif San Francisco, Dept Med, Carol Franc Buck Breast Canc Ctr, San Francisco, CA 94930 USA

[2] Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94930 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 04期

关键词：

D O I：

10.1053/sonc.2001.25443

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：86 / 91

页数：6

共 24 条

[1]

Blamey R, 1999, EUR J SURG ONCOL, V25, P3

[2] Current use of bisphosphonates in oncology [J].

Body, JJ ;

Bartl, R ;

Burckhardt, P ;

Delmas, PD ;

Diel, IJ ;

Fleisch, H ;

Kanis, JA ;

Kyle, RA ;

Mundy, GR ;

Paterson, AHG ;

Rubens, RD .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) :3890-3899

[3]

Boissier S, 2000, CANCER RES, V60, P2949

[4]

Boissier S, 1997, CANCER RES, V57, P3890

[5] Progressive osteoporosis during androgen deprivation therapy for prostate cancer [J].

Daniell, HW ;

Dunn, SR ;

Ferguson, DW ;

Lomas, G ;

Niazi, Z ;

Stratte, PT .

JOURNAL OF UROLOGY, 2000, 163 (01) :181-186

[6] Reduction in new metastases in breast cancer with adjuvant clodronate treatment [J].

Diel, IJ ;

Solomayer, EF ;

Costa, SD ;

Gollan, C ;

Goerner, R ;

Wallwiener, D ;

Kaufmann, M ;

Bastert, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06) :357-363

[7]

DIEL IJ, 1999, EUR J CANC S4, V35, pA269

[8]

Diel Ingo J., 2000, Cancer, V88, P3080, DOI 10.1002/1097-0142(20000615)88:12+<3080::AID-CNCR27>3.0.CO

[9]

2-W

[10] Cost utility analysis of prophylactic pamidronate for the prevention of skeletal related events in patients with advanced breast cancer [J].

Dranitsaris, G ;

Hsu, T .

SUPPORTIVE CARE IN CANCER, 1999, 7 (04) :271-279

← 1 2 3 →